For young women diagnosed with cancer, the chance to preserve future fertility can be as consequential as the treatment itself — yet whether that option is even discussed appears to depend heavily on race, insurance status, and socioeconomic standing rather than medical need alone. This reality, now documented at scale, challenges oncology's assumption that fertility counseling is becoming routine care.
A systematic review published in Cancer synthesized 25 U.S.-based studies drawn from 10,151 screened records, covering female adolescents and young adults (AYAs) aged 15–39 with cancer diagnoses between 2006 and 2025. The findings expose an extraordinary range of outcomes: fertility preservation discussions occurred in as few as 9% and as many as 75% of eligible patients; referrals to reproductive specialists spanned 0.9% to 57%; and actual procedure completion ranged from just 0.56% to 70.3%. This variance alone signals systemic inconsistency rather than individual clinical judgment. Facilitators of access included younger age, private insurance, nulliparity, higher socioeconomic status, and more recent diagnosis year — suggesting incremental improvement over time but no structural resolution.
The breadth of these disparities is not surprising in isolation — reproductive medicine and oncology have long operated in parallel silos — but this review's scope and methodological rigor (all 25 studies rated high quality with low bias risk using Joanna Briggs Institute tools) lend the findings unusual authority. The identified barriers mirror broader healthcare equity patterns: uninsured or publicly insured patients, racial and ethnic minorities, and lower-income patients consistently appear underserved. What makes this finding particularly significant is that fertility preservation, unlike many cancer-adjacent interventions, has a narrow treatment window; delays caused by access inequity are often irreversible. The review's reliance on observational data means causality cannot be established, and the wide procedural completion range reflects both institutional variation and differing patient populations. Still, the convergent signal across 25 independent studies elevates this beyond incremental findings — it represents a reproducible, systemic failure demanding structural intervention at oncology intake, not just provider education.